The Role of Artificial Intelligence in Advancing Diagnosis, Treatment, and Scientific Research across Medical Disciplines: An Applied Study on the Integration of Medicine, Pharmacy, Biotechnology, and Public Health
Abstract
Artificial intelligence (AI) entry into medical disciplines is a paradigm change in health practice, research, and patient care. In this comprehensive study, the trends of AI implementation, performance, and implementation challenges were examined in four of the largest areas of healthcare: clinical medicine, pharmacy, biotechnology, and public health. A mixed-methods protocol including systematic review of 247 studies (2018-2024), cross-sectional surveys of 847 healthcare professionals, semi-structured interviews of 85 AI researchers, and case study analysis of high-impact AI implementations across domains. Quantitative statistical analysis and qualitative thematic analysis were employed to analyze data. AI demonstrated considerable performance improvement across all fields with diagnostic accuracy ranging from 52.1% to 94% depending on application domains. Physician AI adoption increased from 52% in 2023 to 66% in 2024. AI drug discovery increased from a market of $1.5 billion in 2023 to $2.1 billion in 2024 and is expected to be $15.8 billion by 2030. Cross-disciplinary analysis revealed the varying levels of maturity: biotechnology (3.8/5 maturity score), medicine (3.2/5), pharmacy (2.8/5), and public health (2.4/5). Barriers to implementation were high costs (73.2%), technical expertise limitation (68.9%), and concerns over data privacy (67.4%). Adoption of AI is of great potential in all specialties of medicine with evidence of improved diagnostic accuracy, better efficiency, and cost-effectiveness. Effective implementation, nonetheless, requires overcoming specialty-specific challenges and maximizing common success factors. The disparity between laboratory AI performance and field practice in healthcare underscores the need for continued research, harmonization of frameworks, and large-scale training efforts.
Letters in High Energy Physics (LHEP) is an open access journal. The articles in LHEP are distributed according to the terms of the creative commons license CC-BY 4.0. Under the terms of this license, copyright is retained by the author while use, distribution and reproduction in any medium are permitted provided proper credit is given to original authors and sources.
Terms of Submission
By submitting an article for publication in LHEP, the submitting author asserts that:
1. The article presents original contributions by the author(s) which have not been published previously in a peer-reviewed medium and are not subject to copyright protection.
2. The co-authors of the article, if any, as well as any institution whose approval is required, agree to the publication of the article in LHEP.